diphenylamine has been researched along with su 11248 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnard, J; Diaz-Montero, CM; Finke, JH; Lindner, DJ; Mao, FJ; Parker, Y; Pink, JJ; Rini, BI; Zamanian-Daryoush, M | 1 |
Ng, MF; Okuda, KS; Patel, V; Ruslan, NF; Samat, N; Tan, PJ | 1 |
2 other study(ies) available for diphenylamine and su 11248
Article | Year |
---|---|
MEK inhibition abrogates sunitinib resistance in a renal cell carcinoma patient-derived xenograft model.
Topics: Adult; Animals; Benzamides; Carcinoma, Renal Cell; Cell Line, Tumor; Diphenylamine; Drug Resistance, Neoplasm; Drug Synergism; Gene Expression Regulation, Neoplastic; Humans; Indoles; Kidney Neoplasms; Male; MAP Kinase Signaling System; Mice; Mice, Inbred NOD; Mice, Knockout; Mice, SCID; Mitogen-Activated Protein Kinase Kinases; Myeloid-Derived Suppressor Cells; Neoplasm Proteins; Neovascularization, Pathologic; Phosphorylation; Protein Kinase Inhibitors; Protein Processing, Post-Translational; Pyrroles; Receptors, Interleukin-2; Sunitinib; Tumor Burden; Tumor Escape; Xenograft Model Antitumor Assays | 2016 |
Interference Potential of Tannins and Chlorophylls in Zebrafish Phenotypic-Based Assays.
Topics: Angiogenesis Inhibitors; Animals; Benzamides; Chlorophyll; Diphenylamine; Drug Evaluation, Preclinical; Phenotype; Sunitinib; Tannins; Zebrafish | 2018 |